Anti-IF/ CBLIF/ GIF functional antibody

Anti-IF/ CBLIF/ GIF functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CBLIF/CBLIF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0730-Ab-1/ GM-Tg-hg-SE0730-Ab-2Anti-Human CBLIF monoclonal antibodyHuman
GM-Tg-rg-SE0730-Ab-1/ GM-Tg-rg-SE0730-Ab-2Anti-Rat CBLIF monoclonal antibodyRat
GM-Tg-mg-SE0730-Ab-1/ GM-Tg-mg-SE0730-Ab-2Anti-Mouse CBLIF monoclonal antibodyMouse
GM-Tg-cynog-SE0730-Ab-1/ GM-Tg-cynog-SE0730-Ab-2Anti-Cynomolgus/ Rhesus macaque CBLIF monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0730-Ab-1/ GM-Tg-felg-SE0730-Ab-2Anti-Feline CBLIF monoclonal antibodyFeline
GM-Tg-cang-SE0730-Ab-1/ GM-Tg-cang-SE0730-Ab-2Anti-Canine CBLIF monoclonal antibodyCanine
GM-Tg-bovg-SE0730-Ab-1/ GM-Tg-bovg-SE0730-Ab-2Anti-Bovine CBLIF monoclonal antibodyBovine
GM-Tg-equg-SE0730-Ab-1/ GM-Tg-equg-SE0730-Ab-2Anti-Equine CBLIF monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0730-Ab-1/ GM-Tg-hg-SE0730-Ab-2; GM-Tg-rg-SE0730-Ab-1/ GM-Tg-rg-SE0730-Ab-2;
GM-Tg-mg-SE0730-Ab-1/ GM-Tg-mg-SE0730-Ab-2; GM-Tg-cynog-SE0730-Ab-1/ GM-Tg-cynog-SE0730-Ab-2;
GM-Tg-felg-SE0730-Ab-1/ GM-Tg-felg-SE0730-Ab-2; GM-Tg-cang-SE0730-Ab-1/ GM-Tg-cang-SE0730-Ab-2;
GM-Tg-bovg-SE0730-Ab-1/ GM-Tg-bovg-SE0730-Ab-2; GM-Tg-equg-SE0730-Ab-1/ GM-Tg-equg-SE0730-Ab-2
Products NameAnti-CBLIF monoclonal antibody
Formatmab
Target NameCBLIF
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CBLIF benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0730-Ag-1Recombinant multi-species IF/ CBLIF/ GIF protein
    ORF Viral VectorvGMLP003781human GIF Lentivirus particle
    ORF Viral VectorpGMLP003781human GIF Lentivirus plasmid


    Target information

    Target IDGM-SE0730
    Target NameCBLIF
    Gene ID2694,29319,698704,449477,101101254,616252,100060988
    Gene Symbol and SynonymsCBLIF,GIF,IF,IFMH,INF,TCN3
    Uniprot AccessionP27352,P17267,Q5XWD5
    Uniprot Entry NameIF_HUMAN,IF_RAT,IF_CANLF
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134812
    Target ClassificationN/A

    The target: CBLIF, gene name: CBLIF, also named as GIF, IF, IFMH, INF, TCN3. This gene is a member of the cobalamin transport protein family. It encodes a glycoprotein secreted by parietal cells of the gastric mucosa and is required for adequate absorption of vitamin B12. Vitamin B12 is necessary for erythrocyte maturation and mutations in this gene may lead to congenital pernicious anemia. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.